Login / Signup

Case series of a hybrid closed-loop system used in pregnancies in clinical practice.

Sarit PolskyHalis K Akturk
Published in: Diabetes/metabolism research and reviews (2019)
CareLink® Clinical Software only reports the non-pregnant time in range. Nonetheless, this represents the first report of HCL therapy in pregnancy with a system approved by the Food and Drug Administration in non-pregnant populations.
Keyphrases
  • drug administration
  • clinical practice
  • preterm birth
  • pregnant women
  • pregnancy outcomes
  • gestational age
  • data analysis
  • mesenchymal stem cells
  • stem cells
  • risk assessment
  • genetic diversity
  • climate change
  • cell therapy